Today’s Solutions: April 04, 2025

Remember the ALS Ice Bucket Challenge? Well, apparently the more than $200 million raised worldwide through the challenge helped fund an experimental medication that may slow the progression of amyotrophic lateral sclerosis, or ALS.

Although this medication is not a cure, it may slow the inexorable disability caused by ALS, which destroys the nerve cells that control the muscles that allow us to move, speak, eat and even breathe. The treatment targets two cellular structures damaged by the disease: the mitochondria, which are the cells’ power plants, and the endoplasmic reticulum, the cellular dump trucks that cart away waste that can gunk up the cells’ machinery.

The multicenter, randomized, double-blind study is the second step — a phase 2 trial — in a three-step process required by the Food and Drug Administration for drug approval. In a double-blind study, neither the patients nor the researchers know who is receiving the drug. If a phase 2 study generates positive results, the FDA typically requires a larger and longer phase 3 trial.

During the six months of the study, which recruited 137 people with ALS, the control group of patients saw a 25 percent better functional outcome than the placebo group. Dr. Sabrina Paganoni, a neuromuscular specialist at Massachusetts General Hospital’s Sean M. Healey & AMG Center for ALS, said that if the drug is approved, it would likely be just one part of a combination of medications that could keep ALS at bay.

Solutions News Source Print this article
More of Today's Solutions

Friendships across income lines boost social mobility, study shows

BY THE OPTIMIST DAILY EDITORIAL TEAM A new study has found that friendships bridging economic divides can meaningfully improve social mobility—and even boost future ...

Read More

New cat color unlocked: ’salty liquorice’ sheds light on feline genetics

BY THE OPTIMIST DAILY EDITORIAL TEAM In a surprising turn for feline genetics, scientists have officially identified a new cat coat color that defies ...

Read More

3 myths about self-help and personal growth we should all stop believing

BY THE OPTIMIST DAILY EDITORIAL TEAM When you hear the term "self-help," you may envision a stack of books with catchy, motivational titles. However, ...

Read More

Do you have a toxic friend? A therapist’s advice on how to set boundaries 

BY THE OPTIMIST DAILY EDITORIAL TEAM Friendships can be a source of joy and comfort, but unfortunately, even the most intimate connections can become toxic. ...

Read More